Kenneth L. Zeitzer

1.5k citations

22 papers · 297 indexed · h-index 10

Pulmonary and Respiratory Medicine top 10%
- Prostate Cancer Treatment and Research 19
- Prostate Cancer Diagnosis and Treatment 18
- Sarcoma Diagnosis and Treatment 1
Radiation top 10%
- Advanced Radiotherapy Techniques 10
Cancer Research
- Cancer, Lipids, and Metabolism 2
Statistics and Probability
- Statistical Methods in Clinical Trials 2
Endocrinology, Diabetes and Metabolism
- Hormonal and reproductive studies 3
Hepatology
- Hepatocellular Carcinoma Treatment and Prognosis 2

Co-authors: Howard M. Sandler Christopher U. Jones Thomas M. Pisansky Seth A. Rosenthal Eric M. Horwitz Herbert Lepor David J. Grignon Jean-Paul Bahary
Cited by: Pulmonary and Respiratory Medicine Radiation Cancer Research
Journals: Journal of Clinical Oncology (5 papers)International Journal of Radiation Oncology*Biology*Physics (12 papers)European Urology (1 paper)
Partner nations: United States Canada Argentina

In The Last Decade

Kenneth L. Zeitzer

22 papers receiving 295 citations

Peers

Countries citing papers authored by Kenneth L. Zeitzer

Since Specialization

Citations

This map shows the geographic impact of Kenneth L. Zeitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth L. Zeitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth L. Zeitzer more than expected).

Fields of papers citing papers by Kenneth L. Zeitzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth L. Zeitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth L. Zeitzer. The network helps show where Kenneth L. Zeitzer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kenneth L. Zeitzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kenneth L. Zeitzer Line = papers co-authored together Kenneth L. Zeitzer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy International Journal of Radiation OncologyBiologyPhysics ·Himu Lukka,Stephanie L. Pugh,William U. Shipley,Pierre Major,Oliver Sartor,Ian S. Dayes,Jean-Paul Bahary,Jason A. Efstathiou,Thomas M. Pisansky,Kenneth L. Zeitzer,C.A. Lawton,Robert T. Dess,Andrew S Camarata,Alexander G. Balogh,Luís Souhami,Seth A. Rosenthal,J.D.D. Pennington,Wendy Seiferheld,Felix Y. Feng,Howard M. Sandler	2025	1
2	Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 Journal of Clinical Oncology ·Will Jackson,Ming Tang,Matthew J. Schipper,Howard M. Sandler,Zachary S. Zumsteg,Jason A. Efstathiou,William U. Shipley,Wendy Seiferheld,Himanshu Lukka,Jean-Paul Bahary,Anthony L. Zietman,Thomas M. Pisansky,Kenneth L. Zeitzer,William A. Hall,Robert T. Dess,R.D. Lovett,Alexander G. Balogh,Felix Y. Feng,Daniel E. Spratt	2022	12
3	Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902 Radiotherapy and Oncology ·Daniel A. Hamstra,Stephanie L. Pugh,Herbert Lepor,Seth A. Rosenthal,Kenneth J. Pienta,Leonard G. Gomella,Christopher A. Peters,David D’Souza,Kenneth L. Zeitzer,Christopher U. Jones,William A. Hall,Eric M. Horwitz,Thomas M. Pisansky,Luís Souhami,Alan C. Hartford,M.M. Dominello,Felix Y. Feng,Howard M. Sandler	2019	6
4	Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials International Journal of Radiation OncologyBiologyPhysics ·Christopher L. Hallemeier,Peixin Zhang,Thomas M. Pisansky,Gerald E. Hanks,D.G. McGowan,Mack Roach,Kenneth L. Zeitzer,S. Firat,Siraj Husain,David D’Souza,Luís Souhami,Matthew Parliament,Seth A. Rosenthal,Himanshu Lukka,Marvin Rotman,Eric M. Horwitz,Edward F. Miles,Rebecca Paulus,Howard M. Sandler	2019	7
5	Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities Advances in Radiation Oncology ·Canhua Xiao,Jennifer Moughan,Benjamin Movsas,André Konski,Gerald E. Hanks,James D. Cox,Mack Roach,Kenneth L. Zeitzer,C.A. Lawton,Christopher A. Peters,Seth A. Rosenthal,I.-Chow Hsu,Eric M. Horwitz,Mark V. Mishra,Jeff M. Michalski,Matthew Parliament,David D’Souza,Stephanie L. Pugh,Deborah Watkins Bruner	2018	2
6	Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202 Journal of Clinical Oncology ·James J. Dignam,Daniel A. Hamstra,Herbert Lepor,David J. Grignon,Harmar D. Brereton,Adam Currey,Seth A. Rosenthal,Kenneth L. Zeitzer,Varagur Venkatesan,Eric M. Horwitz,Thomas M. Pisansky,Howard M. Sandler	2018	13
7	Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202 International Journal of Radiation OncologyBiologyPhysics ·C.A. Lawton,Xiaolei Lin,Gerald E. Hanks,Herbert Lepor,David J. Grignon,Harmar D. Brereton,Meena Bedi,Seth A. Rosenthal,Kenneth L. Zeitzer,Varagur Venkatesan,Eric M. Horwitz,Thomas M. Pisansky,Harold Kim,Matthew Parliament,Rachel Rabinovitch,Mack Roach,Young Kwok,James J. Dignam,Howard M. Sandler	2017	76
8	Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408 Advances in Radiation Oncology ·R.C. Nichols,Chen Hu,Jean-Paul Bahary,Kenneth L. Zeitzer,Luís Souhami,Mark H. Leibenhaut,Marvin Rotman,Elizabeth Gore,Alexander G. Balogh,D.G. McGowan,Jeff M. Michalski,Adam Raben,Shari Rudoler,Christopher U. Jones,Howard M. Sandler	2017	13
9	Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202 International Journal of Radiation OncologyBiologyPhysics ·Amin Mirhadi,Qiang Zhang,Gerald E. Hanks,Herbert Lepor,David J. Grignon,Christopher A. Peters,Seth A. Rosenthal,Kenneth L. Zeitzer,John Radwan,C.A. Lawton,Matthew Parliament,Robert Reznik,Howard M. Sandler	2016	6
10	Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408 International Journal of Radiation OncologyBiologyPhysics ·Daniel Krauss,Chen Hu,Jean-Paul Bahary,Luís Souhami,Elizabeth Gore,Susan Chafe,Mark H. Leibenhaut,Samir Narayan,Javier F. Torres–Roca,Jeff M. Michalski,Kenneth L. Zeitzer,Viroon Donavanik,Howard M. Sandler,D.G. McGowan,Christopher U. Jones,William U. Shipley	2015	22
11	Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG Oncology/RTOG 9202 International Journal of Radiation OncologyBiologyPhysics ·C.A. Lawton,James J. Dignam,G. Hanks,Herbert Lepor,David Grignon,Harmar D. Brereton,Meena Bedi,Seth A. Rosenthal,Kenneth L. Zeitzer,V. Venkatesan,Eric M. Horwitz,Thomas M. Pisansky,H. Kim,M.B. Parliament,Young Kwok,Mack Roach,Xiaowen Lin,Howard M. Sandler	2015	4
12	Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08 European Urology ·Justin C. Voog,Rebecca Paulus,William U. Shipley,Matthew R. Smith,D.G. McGowan,Christopher U. Jones,Jean-Paul Bahary,Kenneth L. Zeitzer,Luís Souhami,Mark H. Leibenhaut,Marvin Rotman,Siraj Husain,Elizabeth Gore,Adam Raben,Susan Chafe,Howard M. Sandler,Jason A. Efstathiou	2015	32
13	Ki-67 Is an Independent Predictor of Metastasis and Cause-Specific Mortality for Prostate Cancer Patients Treated on Radiation Therapy Oncology Group (RTOG) 94-08 International Journal of Radiation OncologyBiologyPhysics ·Bret Verhoven,Yan Yan,Mark A. Ritter,Li‐Yan Khor,Elizabeth Hammond,Christopher U. Jones,Mahul B. Amin,Jean-Paul Bahary,Kenneth L. Zeitzer,Alan Pollack	2013	39
14	Serum Testosterone Changes in Patients Treated With Radiation Therapy Alone for Prostate Cancer on RTOG 9408 International Journal of Radiation OncologyBiologyPhysics ·R.C. Nichols,Asha George,Jean-Paul Bahary,Kenneth L. Zeitzer,Luís Souhami,Mark H. Leibenhaut,Marvin Rotman,Elizabeth Gore,A.G. Balogh,C.U. Jones	2013	1
15	Radiation Therapy Oncology Group (RTOG) 9408: A Secondary Analysis of the Risk of Death From Second Cancers Comparing Whole Pelvic (WP) Radiation Therapy (RT) to Prostate Only (PO) RT and Neoadjuvant Hormonal Therapy (NHT) + RT to RT Alone International Journal of Radiation OncologyBiologyPhysics ·Mack Roach,Daniel Hunt,C.U. Jones,Jean-Paul Bahary,Kenneth L. Zeitzer,Luís Souhami,Mark H. Leibenhaut,Marvin Rotman,Elizabeth Gore,Howard M. Sandler	2013	1
16	Gleason Pattern 5 is Associated With an Increased Risk for Metastasis Following Androgen Deprivation Therapy (ADT) and Radiation: An Analysis of RTOG 9202 and 9902 International Journal of Radiation OncologyBiologyPhysics ·D.A. Hamstra,Dylan Hunt,David Grignon,Gerald E. Hanks,Craig A. Peters,Seth A. Rosenthal,Michael Lock,Kenneth L. Zeitzer,L. Souhami,Howard Sandler	2012	1
17	Radiation Therapy Oncology Group (RTOG) 9413: Randomized trial comparing whole pelvic radiotherapy (WPRT) to prostate only (PORT) and neoadjuvant hormone therapy (NHT) to adjuvant hormone therapy (AHT). Journal of Clinical Oncology ·Mack Roach,Yan Yan,C.A. Lawton,I‐Chow Hsu,Robert A. Lustig,Christopher U. Jones,Marvin Rotman,Kenneth L. Zeitzer,Maria Werner‐Wasik,Harold Kim,Charles R. Thomas,William U. Shipley,Howard M. Sandler	2012	2
18	A phase III protocol of androgen suppression (AS) and radiation therapy (RT) versus AS and RT followed by chemotherapy with paclitaxel, estramustine, and etoposide (TEE) for localized, high-risk, prostate cancer, RTOG 9902. Journal of Clinical Oncology ·Howard M. Sandler,Daniel Hunt,Oliver Sartor,Leonard G. Gomella,Alan C. Hartford,Kenneth L. Zeitzer,R. Rajan,K. Kerlin,J.M. Michalski,Seth A. Rosenthal	2010	6
19	Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients. PubMed ·Sucha O. Asbell,K. C. Raimane,Angelica T. Montesano,Kenneth L. Zeitzer,Matthew D. Asbell,Srinivasan Vijayakumar	2000	19
20	A phase II trial evaluation selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma International Journal of Radiation OncologyBiologyPhysics ·William F. Regine,James Fontanesi,Parvesh Kumar,Kenneth L. Zeitzer,Carol Greenwald,Laura C. Bowman,David N. Shapiro,Bhaskar N. Rao,Larry E. Kun	1995	11

About Kenneth L. Zeitzer

Kenneth L. Zeitzer is a scholar working on Radiation, Pulmonary and Respiratory Medicine and Hepatology, having authored 22 papers that have together received 297 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (18 papers), Advanced Radiotherapy Techniques (10 papers), Hormonal and reproductive studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer, Lipids, and Metabolism (2 papers), Statistical Methods in Clinical Trials (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (255 citations), Radiation (49 citations) and Cancer Research (42 citations). Kenneth L. Zeitzer has collaborated with scholars based in United States, Canada and Argentina. Frequent co-authors include Howard M. Sandler, Christopher U. Jones, Thomas M. Pisansky, Seth A. Rosenthal, Eric M. Horwitz, Herbert Lepor, David J. Grignon, Jean-Paul Bahary, Luís Souhami and C.A. Lawton. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact